Urolithin A: Potential To Enhance Autophagic Clearance And Mitigate Neuroinflammation In Alzheimer’S Disease
Scientists are exploring new ways to combat Alzheimer’s disease, a condition characterized by impaired cellular cleanup and inflammation in the brain. A promising compound, Urolithin A, a natural substance produced by gut microbes from foods like pomegranates and berries, has shown potential in recent research. This compound works by boosting a vital cellular process called mitophagy, which is responsible for clearing out damaged components within cells, particularly mitochondria (the cell’s powerhouses). In studies using mouse models of Alzheimer’s, long-term treatment with Urolithin A significantly improved cognitive abilities such as learning, memory, and even the sense of smell. It also helped reduce the accumulation of harmful proteins like amyloid beta and tau, which are hallmarks of the disease. Furthermore, Urolithin A was found to restore the normal function of lysosomes, which are like the recycling centers of cells, partly by regulating a specific protein called cathepsin Z. These findings suggest that Urolithin A could play a crucial role in modulating the brain’s immune responses and other disease-specific pathways, offering a new avenue for therapeutic development by addressing the critical issue of cellular waste accumulation in Alzheimer’s.
Source: link to paper